Navigation Links
Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
Date:4/28/2008

employee benefits 17,929 20,997

Other accrued expenses 4,977 4,014

Income tax payable 13,957 846

Deferred revenue - short term 2,957 2,836

Total current liabilities 54,765 40,470

Non-current income tax payable 4,341 3,958

Deferred income tax - long term 75 75

Deferred revenue - long term 4,441 4,607

Deferred rent - 10

Deferred compensation plan liabilities 2,348 1,893

Commitments and contingencies

Stockholders' equity:

Preferred stock, $.0001 par value per share,

20,000,000 shares authorized, none issued and

outstanding - -

Common stock, $.0001 par value per share;

200,000,000 shares authorized, 53,992,269 and

53,916,298 shares issued and outstanding at

March 31, 2008 and December 31, 2007, respectively 5 5

Additional paid-in capital 423,452 415,229

Accumulated other comprehensive income 2,974 1,604

Retained earnings 353,147 321,202

Total stockholders' equity 779,578 738,040

Total liabilities and stockholders' equity $845,548 $789,053

Gen-Probe Incorporated

Consolidated Statements of Income

(In thousands, except per share data)

Three Months Ended

March 31,


'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
2. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
3. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
4. Carl Hull Named President and Chief Operating Officer of Gen-Probe
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
6. Gen-Probe to Webcast Three Upcoming Presentations
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
9. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
10. CV Therapeutics Reports 2008 First Quarter Financial Results
11. Caliper Life Sciences Reports West Coast Consolidation of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... AUSTIN, Texas , Dec. 24, 2014 /PRNewswire/ ... company focused on gynecologic disease, announced today that ... with investors including Oracle Investment Management, Jack ... Vermillion directors. Total proceeds were $10.5 million, before ... working capital and general corporate purposes. ...
(Date:12/24/2014)... 2014 Earlier this year in a ... director of the Adult Stem Cell Technology Center, LLC ... and under appreciated unique property of adult tissue stem ... Cells: Misunderstood in the Past, Important for the Future,” ... He gave the address at the 4th World ...
(Date:12/24/2014)... Texas (PRWEB) December 23, 2014 ... methyl mercaptan such as its definition, classification, ... presents product specification, manufacturing process, and product ... technology and applications. The analysis also covers ... marketing channels, industry development trend and proposals. ...
(Date:12/24/2014)... , Dec. 23, 2014 China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that its majority-owned subsidiary, Shandong Taibang Biological Products ... certification from the China Food and Drug Administration ... facility. As previously disclosed in the Company,s public ...
Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3
... January 22 Amsterdam Molecular,Therapeutics (Euronext: AMT), a leader ... Dr. Ronald H.W. Lorijn will for personal reasons retire,as ... van,Deventer, AMT,s chief scientific officer and co-founder of the ... basis. , Since Ronald Lorijn ...
... MichBio, the association for,Michigan,s biosciences industry, is ... Michigan Biosciences Directory and Resource Guide, the most,comprehensive ... and,organizations. The directory will be included in the ... spotlighting Michigan,biosciences news and trends. , ...
... NEW ROCHELLE, N.Y., Jan. 22 Biotechnology companies ... microfluidics techniques over the past decade and are ... in three years, reports Genetic Engineering and ... ). The technology offers a number of advantages, ...
Cached Biology Technology:AMT CEO Ronald Lorijn Steps Down 2AMT CEO Ronald Lorijn Steps Down 3MichBio Will Publish 2009 Michigan Biosciences Directory and Resource Guide 2GEN Reports on Growing Reliance on Microfluidics Technology 2
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the leading ... study that pinpoints fine-scale differences in genetic ancestry of ... . Since immigrants first arrived more than ... has served as a meeting place for ... history and the ongoing mixing of peoples with African, ...
(Date:12/17/2014)... BELVOIR, Va. , Dec. 15, 2014 /PRNewswire-USNewswire/ ... efforts to make it easier to detect and ... chain. Today the agency started performing ... The capability will validate the authenticity of purchased ... chain. The new quality control measures will be ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and ... the addition of the "Global Chemical Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... the increasing demand for medical sensors in biomedical ... data for quick and correct diagnosis during surgical ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... With the increasing popularity of whitening one,s teeth, ... of the University of Rochester Medical Center, set out ... tooth from using whitening products. Eastman Institute,s YanFang ... effects of 6 percent hydrogen peroxide, the common ingredient ...
... cellular backup of our brain. These cells are capable ... into neurons, astrocytes or oligodendrocytes. Astrocytes have supportive functions ... myelin layer around axons in order to accelerate neuronal ... know" which way it is supposed to develop? On ...
... will present societal awards to five distinguished ecologists at ... Albuquerque, New Mexico. More than 3,500 attendees are expected ... Steven Hubbell , Steven Hubbell of the University of ... will receive this year,s Eminent Ecologist Award, given to ...
Cached Biology News:OJ worse for teeth than whitening says Eastman Institute researchers 2Neural stem cell differentiation factor discovered 2Ecological Society of America announces 2009 award recipients 2Ecological Society of America announces 2009 award recipients 3
... The Z-Competent E. coli Transformation Buffer ... of competent E. coli cells for simple ... method completely eliminates the requirement for heat ... transformation can be performed by adding DNA ...
Request Info...
Buffer used for mitocapture assays....
... automated perfusion system. For real-time or ... biophysics, electrochemistry, or general liquid-handling research ... millisecond accuracy Run experiments automatically ... accuracy and flexibility Turnkey perfusion ...
Biology Products: